DCF — BERGEN NEW BRIDGE MEDICAL CENTER
Enterprise Value: $-165.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-165.4M
Enterprise Value
$-55.3M
PV of Cash Flows
$-110.0M
PV of Terminal Value
$-177.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $192.6M | $-8.7M | -4.0% | $-16.8M | $-15.3M |
| Year 2 | $198.4M | $-6.9M | -3.0% | $-15.3M | $-12.7M |
| Year 3 | $204.3M | $-5.1M | -2.0% | $-13.8M | $-10.3M |
| Year 4 | $210.4M | $-4.2M | -2.0% | $-13.1M | $-9.0M |
| Year 5 | $216.8M | $-3.8M | -2.0% | $-13.0M | $-8.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-165.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$187.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999759323834
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5